NCT04010422 is a clinical trial of no intervention in Autism, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT04010422?

NCT04010422 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT04010422?

Interventions in NCT04010422: no intervention.

What condition does NCT04010422 study?

NCT04010422 studies Autism, Ocular Surface Disease.

Is NCT04010422 still recruiting?

NCT04010422 is currently status unknown. Last updated 18 April 2023.

Last reviewed 2023-04-18 · How we verify

NCT04010422

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ocular Function in Autism Spectrum Disorder

Status unknown Last updated 18 April 2023

What this trial tests

trial testing no intervention in Autism in 100 participants. Status unknown.

Timeline

15 May 2019

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	National Taiwan University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	15 May 2019
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across Taiwan

Drugs / interventions tested

no intervention

Conditions studied

Autism — all drugs for Autism →
Ocular Surface Disease — all drugs for Ocular Surface Disease →

Sponsor

National Taiwan University Hospital

Who can join

20 and older, any sex, with Autism or Ocular Surface Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate the visual function in individuals with ASD, with a particular focus on the ocular surface condition and visual function assessment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

All-Cause Mortality and Specific Causes of Death in Autism: A Nationwide Analysis.
Wu CS, Tsai HJ, Chien YL, Gau SS. · · 2025 · cited 4× · PMID 40151655 · DOI 10.1089/aut.2023.0103

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

NCT07480057 — Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry · recruiting
NCT07253506 — Turkish Adaptation, Validity, and Reliability Study of the Patient Experience With Treatment and Self-Management Scale i · not yet recruiting
NCT07253519 — The Relationship Between Mood and Insomnia Severity and Caregiver Burden in Caregivers of Stroke · not yet recruiting
NCT07194096 — Stress Hyperglycemia Ratio and Postoperative Delirium · not yet recruiting
NCT07240337 — Botulinum Toxin Applications in Hemiplegic Patients · recruiting

Other recruiting trials for Autism

Currently open trials in the same condition.

NCT07367256 — Using Virtual Reality to Improve Emotion Understanding in Children With Autism · NA · recruiting
NCT06853665 — The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine · Phase 4 · recruiting
NCT06523387 — Online Pivotal Response Treatment Training in Autism Spectrum Disorder · NA · recruiting
NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study · Phase 1, PHASE2 · recruiting
NCT07403396 — Static Balance Assessment in Children With ASD Using VRRS · recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04010422 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 18 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04010422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing